ENAMINE Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:ENAMINE Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C0474
◆発行会社(調査会社):GlobalData
◆発行日:2018年7月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ウクライナ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Enamine Ltd (Enamine) is a provider of screening and drug discovery services. The company’s products include building blocks and intermediates, screening compounds, real database, compound libraries, fragment library, tangible building blocks, materials chemistry and scaffolds. It offers services such as hit follow-up support, custom synthesis, bioanalytical services, molecular screening services, lead optimization, molecular modeling and compound management. Enamine offers database services including screening collection, diversity sets, fragment libraries, targeted libraries and building blocks. The company offers research in the areas of heterocyclic, organofluorine and other chemistries. It operates in the US, Canada, China, Taiwan and Japan. Enamine is headquartered in Kiev, Ukraine.

ENAMINE Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
ENAMINE Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
ENAMINE Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
ENAMINE Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
ENAMINE Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
ENAMINE Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
ENAMINE Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Enamine Enters Agreement with European Molecular Biology Laboratory 10
Enamine Expands Agreement with Actelion 11
Enamine Enters into Drug Discovery Agreement with Pcovery 12
Enamine Enters Into Co-Development Agreement With MRC LMB And IOCB For Rhomboid Protease Inhibitors 13
ENAMINE Enters Into Agreement With UkrOrgSynthesis For Chemical Building Blocks 14
ENAMINE Ltd – Key Competitors 15
ENAMINE Ltd – Key Employees 16
ENAMINE Ltd – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Product News 18
Jun 04, 2018: New REAL Space Navigator Breaks Billion Compound Barrier 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
ENAMINE Ltd, Pharmaceuticals & Healthcare, Key Facts 2
ENAMINE Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
ENAMINE Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
ENAMINE Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
ENAMINE Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
ENAMINE Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Enamine Enters Agreement with European Molecular Biology Laboratory 10
Enamine Expands Agreement with Actelion 11
Enamine Enters into Drug Discovery Agreement with Pcovery 12
Enamine Enters Into Co-Development Agreement With MRC LMB And IOCB For Rhomboid Protease Inhibitors 13
ENAMINE Enters Into Agreement With UkrOrgSynthesis For Chemical Building Blocks 14
ENAMINE Ltd, Key Competitors 15
ENAMINE Ltd, Key Employees 16
ENAMINE Ltd, Subsidiaries 17

List of Figures
ENAMINE Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
ENAMINE Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
ENAMINE Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
ENAMINE Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
ENAMINE Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
ENAMINE Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
ENAMINE Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
ENAMINE Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[ENAMINE Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • SunPower Corp (SPWR):企業の財務・戦略的SWOT分析
    SunPower Corp (SPWR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Rockhopper Exploration PLC (RKH):企業の財務・戦略的SWOT分析
    Summary Rockhopper Exploration Plc (Rockhopper Exploration) is an oil and gas company that acquires, explores and produces crude oil and natural gas properties in the Falkland Islands and the Greater Mediterranean region. The company’s portfolio of production licenses includes PL003a, PL003b, PL004a …
  • Velan Inc (VLN):企業の財務・戦略的SWOT分析
    Velan Inc (VLN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Esprit Holdings Limited
    Esprit Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Esprit Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Mattress Firm Holding Corp.:企業のM&A・事業提携・投資動向
    Mattress Firm Holding Corp. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Mattress Firm Holding Corp. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • Wyndham Destinations, Inc.:企業の戦略・SWOT・財務情報
    Wyndham Destinations, Inc. - Strategy, SWOT and Corporate Finance Report Summary Wyndham Destinations, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • J.B. Hunt Transport Services, Inc. (JBHT):企業の財務・戦略的SWOT分析
    J.B. Hunt Transport Services, Inc. (JBHT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Mayo Clinic:医療機器:M&Aディール及び事業提携情報
    Summary Mayo Clinic (Mayo) is a not-for-profit medical practice and medical research organization. It provides comprehensive medical facilities and programs related to patient care services, research and medical education. It offers specialized medical care with medical departments and centers in mo …
  • Sanquin Blood Supply Foundation:製薬・医療:M&Aディール及び事業提携情報
    Summary Sanquin Blood Supply Foundation (Sanquin) is a provider of blood bank and diagnostic services, plasma derived products, tissues and cells and reagents. It offers blood-related lab tests for hospitals, blood banks, obstetricians practices, pharmaceutical companies, insurance organizations, an …
  • Purdue Pharma LP:製薬・医療:M&Aディール及び事業提携情報
    Summary Purdue Pharma LP (Purdue) is a privately held, US-based pharmaceutical company which develops pharmacologic therapies for the treatment and management of pain. The company undertakes the research, development, manufacture and marketing of prescription medicines and over-the-counter (OTC) med …
  • Mersana Therapeutics Inc (MRSN):製薬・医療:M&Aディール及び事業提携情報
    Summary Mersana Therapeutics Inc (Mersana) formerly Nanopharma Corp is a clinical-stage biopharmaceutical company that offers antibody drug conjugate to improve patients’ lives. The company offers pipeline product XMT-1522, for HER-2 targeted therapies based on its Dolaflexin platform. It utilizes F …
  • Awilco LNG ASA (ALNG):企業の財務・戦略的SWOT分析
    Summary Awilco LNG ASA (Awilco LNG) a subsidiary of Awilhelmsen AS is an oil and gas company that provides LNG transportation programs. The company owns and operates LNG vessels intended for international trading. It offers LNG value chain such as liquefaction, production, regasification, transporta …
  • Impellam Group plc (IPEL):企業の財務・戦略的SWOT分析
    Impellam Group plc (IPEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Centre for Drug Design and Discovery:製薬・医療:M&Aディール及び事業提携情報
    Summary Centre for Drug Design and Discovery (CD3) is a biomedical research institution that discovers new small molecule drugs. The institution operates as an investment fund and technology transfer platform to promote the discovery and development of medicines for all kinds of diseases. It provide …
  • Bausch & Lomb Inc:医療機器:M&Aディール及び事業提携情報
    Summary Bausch & Lomb Inc (Bausch & Lomb), a subsidiary of Valeant Pharmaceuticals International Inc, is a vision-care company with focus on the protection, enhancement and restoration of eyesight. It offers over-the-counter supplements, eye care products, contact lenses, ophthalmic pharmaceuticals, …
  • Australian Leaders Fund Limited:企業の戦略・SWOT・財務分析
    Australian Leaders Fund Limited - Strategy, SWOT and Corporate Finance Report Summary Australian Leaders Fund Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Edgewell Personal Care LLC (EPC):企業の財務・戦略的SWOT分析
    Edgewell Personal Care LLC (EPC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Brunei National Petroleum Company Sendirian Berhad:石油・ガス:M&Aディール及び事業提携情報
    Summary Brunei National Petroleum Company Sendirian Berhad (PetroleumBRUNEI) is an oil and gas company that provides exploration and production of oil and gas. The company offers engineering, procurement, construction, installation, commissioning services, and others. It provides oilfield services, …
  • Indianapolis Power & Light Co:電力:M&Aディール及び事業提携情報
    Summary Indianapolis Power & Light Co (IPL), a subsidiary of IPALCO Enterprises Inc, is an integrated electric utility. The company generates, transmits, distributes, and sells electric energy. It produces electricity from coal, oil, and natural gas sources. IPL owns and operates power plants in Ind …
  • Newron Pharmaceuticals SpA (NWRN):製薬・医療:M&Aディール及び事業提携情報
    Summary Newron Pharmaceuticals SpA (Newron) is a research-based biopharmaceutical company which focuses on the discovery, development and commercialization of novel therapeutic drugs for the treatment of central nervous system disorders and pain. The company’s marketed product, Xadago (safinamide), …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆